Molecular genetics of Alzheimer's disease : What have we learned ?

Acta Neurologica Belgica

Volumn 100, Issue 2, 2000, Pages 65-76

  Van Gassen, Geert ^a   Van Broeckhoven, Christine ^a,b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN;

ALZHEIMER DISEASE; CHROMOSOME 12; GENETIC SCREENING; GENETICS; HUMAN; PATHOLOGY; REVIEW;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; CHROMOSOMES, HUMAN, PAIR 12; GENETIC SCREENING; HUMANS;

EID: 0034203910     PISSN: 03009009     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (105)

1. ALBERTS M. J., GRAFFAGNINO C., MCCLENNY C., DELONG D., STRITTMATTER W. et al. ApoE genotype and survival from intracerebral haemorrhage. Lancet, 1995, 346 : 575.
2. ANCOLIO K., DUMANCHIN C., BARELLI H., WARTER J. M., BRICE A. et al. Unusual phenotypic alteration of beta amyloid precursor protein (betaAPP) maturation by a new Val-715 → Met betaAPP-770 mutation responsible for probable early-onset Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A., 1999, 96 : 4119-4124.
3. ANDREASEN N., MINTHON L., CLARBERG A., DAVIDSSON P., GOTTFRIES J. et al. Sensitivity, specificity, and stability of CSF-tau in AD in a community-based patient sample. Neurology, 1999, 53 : 1488-1494.
4. ANNAERT W. G., LEVESQUE L., CRAESSAERTS K., DIERINCK I., SNELLINGS G. et al. Presenilin 1 Controls gamma-Secretase Processing of Amyloid Precursor Protein in Pre-Golgi Compartments of Hippocampal Neurons. J. Cell Biol., 1999, 147 : 277-294.
5. BALES K. R., VERINA T., CUMMINS D. J., DU Y., DODEL R. C. et al. Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A., 1999, 96 : 15233-15238.
6. BIERER L. M., HOF P. R., PUROHIT D. P., CARLIN L., SCHMEIDLER J. et al. Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease. Arch. Neurol., 1995, 52 : 81-88.
7. BLACKER D., WILCOX M. A., LAIRD N. M., RODES L., HORVATH S. M. et al. Alpha-2 macroglobulin is genetically associated with Alzheimer disease. Nat. Genet., 1998, 19 : 357-360.
8. BLENNOW K., VANMECHELEN E. Combination of the different biological markers for increasing specificity of in vivo Alzheimer's testing. J. Neural Transm. Suppl., 1998, 53 : 223-35 : 223-235.
9. BORNEBROEK M., HAAN J., MAAT-SCHIEMAN M. L., VAN DUINEN S. G., ROOS R. A. Hereditary cerebral hemorrhage with amyloidosis-Dutch type (HCHWA-D) : I - A review of clinical, radiologic and genetic aspects. Brain Pathol., 1996, 6 : 111-114.
10. BRETELER M. M., CLAUS J. J., VAN DUIJN C. M., LAUNER L. J., HOFMAN A. Epidemiology of Alzheimer's disease. Epidemiol. Rev., 1992, 14 : 59-82 : 59-82.
11. CHARTIER-HARLIN M. C., CRAWFORD F., HOULDEN H., WARREN A., HUGHES D. et al. Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene. Nature, 1991, 353 : 844-846.
12. COLLINS F. S. Positional cloning : let's not call it reverse anymore. Nat. Genet., 1992, 1 : 3-6.
13. COLLINS F. S. Positional cloning moves from perditional to traditional. Nat. Genet., 1995, 9 : 347-350.
14. COOK D. G., FORMAN M. S., SUNG J. C., LEIGHT S., KOLSON D. L. et al. Alzheimer's A beta(1-42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells. Nat. Med., 1997, 3 : 1021-1023.
15. CORDER E. H., SAUNDERS A. M., RISCH N. J., STRITTMATTER W. J., SCHMECHEL D. E. et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat. Genet., 1994, 7 : 180-184.
16. CORDER E. H., SAUNDERS A. M., STRITTMATTER W. J., SCHMECHEL D. E., GASKELL P. C. et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science, 1993, 261 : 921-923.
17. CRUTS M., BACKHOVENS H., WANG S. Y., VAN GASSEN G., THEUNS J. et al. Molecular genetic analysis of familial early-onset Alzheimer's disease linked to chromosome 14q24. 3. Hum. Mol. Genet., 1995, 4 : 2363-2371.
18. CRUTS M., VAN DUIJN C., BACKHOVENS H., VAN-DEN BROECK M., WEHNERT A. et al. Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease. Hum. Mol Genet., 1998, 7 : 43-51.
19. DE JONGHE C., CRAS P., VANDERSTICHELE H., CRUTS M., VANDERHOEVEN I. et al. Evidence that Aβ42 plasma levels in presenilin-1 mutation carriers do not allow for prediction of their clinical phenotype. Neurobiol. Dis., 1999a, 6 : 280-287.
20. DE JONGHE C., CRUTS M., ROGAEVA E. A., TYSOE C., SINGLETON A. et al. Aberrant splicing in the presenilin-1 intron 4 mutation causes presenile Alzheimer's disease by increased Aβ42 secretion. Hum. Mol Genet., 1999b, 8 : 1529-1540.
21. DEL-FAVERO J., GOOSSENS D., VAN DEN BOSSCHE D., VAN BROECKHOVEN C. YAC fragmentation with repetitive and single-copy sequences : detailed physical mapping of the presenilin 1 gene on chromosome 14. Gene, 1999, 229 : 193-201.
22. DOAN A., THINAKARAN G., BORCHELT D. R., SLUNT H. H., RATOVITSKY T. et al. Protein topology of presenilin 1. Neuron, 1996, 17 : 1023-1030.
23. ECKMAN C. B., MEHTA N. D., CROOK R., PEREZ-TUR J., PRIHAR G. et al. A new pathogenic mutation in the APP gene (1716V) increases the relative proportion of A beta 42(43). Hum. Mol Genet., 1997, 6 : 2087-2089.
24. GIBSON A. M., SINGLETON A. B., SMITH G., WOODWARD R., MCKEITH I. G. et al. Lack of association of the alpha2-macroglobulin locus on chromosome 12 in AD. Neurology, 2000, 54 : 433-438.
25. GOATE A., CHARTIER H. M., MULLAN M., BROWN J., CRAWFORD F. et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature, 1991, 349 : 704-706.
26. GOLDE T. E., ESTUS S., YOUNKIN L. H., SELKOE D. J., YOUNKIN S. G. Processing of the amyloid protein precursor to potentially amyloidogenic derivatives. Science, 1992, 255 : 728-730.
27. GOLDGABER D., LERMAN M. I., MCBRIDE O. W., SAFFIOTTI U., GAJDUSEK D. C. Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. Science, 1987, 235 : 877-880.
28. GRUNDKE-IQBAL I., IQBAL K., QUINLAN M., TUNG Y. C., ZAIDI M. S. et al. Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J. Biol. Chem., 1986, 261 : 6084-6089.
29. HAASS C., DE STROOPER B. The presenilins in Alzheimer's disease - proteolysis holds the key. Science, 1999, 286 : 916-919.
30. HARDY J. Amyloid, the presenilins and Alzheimer's disease. Trends. Neurosci., 1997, 20 : 154-159.
31. HARTMANN T., BIEGER S. C., BRUHL B., TIENARI P. J., IDA N. et al. Distinct sites of intracellular production for Alzheimer's disease A beta40/42 amyloid peptides. Nat. Med., 1997, 3 : 1016-1020.
32. HENDRIKS L., DE JONGHE C., LUBKE U., WOODROW S., VANDERHOEVEN I. et al. Immunoreactivity of presenilin-1 and tau in Alzheimer's disease brain. Exp. Neurol., 1998, 149 : 341-348.
33. HENDRIKS L., VAN D. C., CRAS P., CRUTS M., VAN H. W. et al. Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene. Nat. Genet., 1992, 1 : 218-221.
34. HUSSAIN I., POWELL D., HOWLETT D. R., TEW D. G., MEEK T. D. et al. Identification of a Novel Aspartic Protease (Asp 2) as beta-Secretase. Mol Cell Neurosci., 1999, 14 : 419-427.
35. HUTTON M., LENDON C. L., RIZZU P., BAKER M., FROELICH S. et al. Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature, 1998, 393 : 702-705.
36. JARRETT J. T., LANSBURY P. T. J. Seeding "one-dimensional crystallization" of amyloid : a pathogenic mechanism in Alzheimer's disease and scrapie ? Cell, 1993, 73 : 1055-1058.
37. KAMBOH M. I., SANGHERA D. K., FERRELL R. E., DEKOSKY S. T. APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism. Nat. Genet., 1995, 10 : 486-488.
38. KANG D. E., SAITOH T., CHEN X., XIA Y., MASLIAH E. et al. Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease. Neurology, 1997, 49 : 56-61.
39. KANG J., LEMAIRE H. G., UNTERBECK A., SALBAUM J. M., MASTERS C. L. et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature, 1987, 325 : 733-736.
40. KEHOE P., WAVRANT-DE V. F., CROOK R., WU W. S., HOLMANS P. et al. A full genome scan for late onset Alzheimer's disease. Hum. Mol Genet., 1999, 8 : 237-245.
41. KOO E. H., SQUAZZO S. L. Evidence that production and release of amyloid beta-protein involves the endocytic pathway. J. Biol. Chem., 1994, 269 : 17386-17389.
42. KOUNNAS M. Z., MOIR R. D., REBECK G. W., BUSH A. I., ARGRAVES W. S. et al. LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted beta-amyloid precursor protein and mediates its degradation. Cell, 1995, 82: 331-340.
43. KOVACS D. M., FAUSETT H. J., PAGE K. J., KIM T. W., MOIR R. D. et al. Alzheimer-associated presenilins 1 and 2 : neuronal expression in brain and localization to intracellular membranes in mammalian cells. Nat. Med., 1996, 2 : 224-229.
44. KWOK J. B., LI Q. X., HALLUPP M., WHYTE S., AMES D. et al. Novel Leu723Pro amyloid precursor protein mutation increases amyloid beta42(43) peptide levels and induces apoptosis. Ann. Neurol., 2000, 47 : 249-253.
45. LAH J. J., HEILMAN C. J., NASH N. R., REES H. D., YI H. et al. Light and electron microscopic localization of presenilin-1 in primate brain. J. Neurosci., 1997, 17: 1971-1980.
46. LEHMANN D. J., JOHNSTON C., SMITH A. D. Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer's disease. Hum. Mol Genet., 1997, 6: 1933-1936.
47. LEVY LAHAD E., POORKAJ P., WANG K., FU Y. H., OSHIMA J. et al. Genomic structure and expression of STM2, the chromosome 1 familial Alzheimer disease gene. Genomics, 1996, 34 : 198-204.
48. LEVY LAHAD E., WIJSMAN E. M., NEMENS E., ANDERSON L., GODDARD K. A. et al. A familial Alzheimer's disease locus on chromosome 1. Science, 1995, 269 : 970-973.
49. LEVY E., CARMAN M. D., FERNANDEZ-MADRID I. J., POWER M. D., LIEBERBURG I. et al. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science, 1990, 248: 1124-1126.
50. LI J., XU M., ZHOU H., MA J., POTTER H. Alzheimer presenilins in the nuclear membrane, interphase kinetochores, and centrosomes suggest a role in chromosome segregation. Cell, 1997, 90 : 917-927.
51. LI X., GREENWALD I. Membrane topology of the C. elegans SEL-12 presenilin. Neuron, 1996, 17 : 1015-1021.
52. LORENZO A., YANKNER B. A. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proc. Natl. Acad. Sci. U.S.A., 1994, 91 : 12243-12247.
53. MA J., YEE A., BREWER H. B. J., DAS S., POTTER H. Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments. Nature, 1994, 372 : 92-94.
54. MAAT-SCHIEMAN M. L., VAN DUINEN S. G., BORNEBROEK M., HAAN J., ROOS R. A. Hereditary cerebral hemorrhage with amyloidosis-Dutch type (HCHWA-D) : II - A review of histopathological aspects. Brain Pathol., 1996, 6 : 115-120.
55. MARTIN J. J., GHEUENS J., BRUYLAND M., CRAS P., VANDENBERGHE A. et al. Early-onset Alzheimer's disease in 2 large Belgian families. Neurology, 1991, 41 : 62-68.
56. MASLIAH E., MALLORY M., GE N., ALFORD M., VEINBERGS I. et al. Neurodegeneration in the central nervous system of apoE-deficient mice. Exp. Neurol., 1995, 136 : 107-122.
57. MATTSON M. P., GOODMAN Y. Different amyloidogenic peptides share a similar mechanism of neurotoxicity involving reactive oxygen species and calcium. Brain Res., 1995, 676 : 219-224.
58. MAYEUX R., SAUNDERS A. M., SHEA S., MIRRA S., EVANS D. et al. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease. N. Engl. J. Med., 1998, 338 : 506-511.
59. MERCKEN M., TAKAHASHI H., HONDA T., SATO K., MURAYAMA M. et al. Characterization of human presenilin 1 using N-terminal specific monoclonal antibodies : Evidence that Alzheimer mutations affect proteolytic processing. FEBS Lett., 1996, 389 : 297-303.
60. MONTOYA S. E., ASTON C. E., DEKOSKY S. T., KAMBOH M. I., LAZO J. S. et al. Bleomycin hydrolase is associated with risk of sporadic Alzheimer's disease. Nat. Genet., 1998, 18 : 211-212.
61. MULLAN M., CRAWFORD F., AXELMAN K., HOULDEN H., LILIUS L. et al. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Nat. Genet., 1992, 1 : 345-347.
62. MURRELL J., FARLOW M., GHETTI B., BENSON M. D. A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science, 1991, 254: 97-99.
63. NAKAI T., YAMASAKI A., SAKAGUCHI M., KOSAKA K., MIHARA K. et al. Membrane topology of Alzheimer's disease-related presenilin 1. Evidence for the existence of a molecular species with a seven membrane-spanning and one membrane-embedded structure. J. Biol. Chem., 1999, 274 : 23647-23658.
64. NAMBA Y., TOMONAGA M., KAWASAKI H., OTOMO E., IKEDA K. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res., 1991, 541 : 163-166.
65. NEWMAN M. F., CROUGHWELL N. D., BLUMENTHAL J. A., LOWRY E., WHITE W. D. et al. Predictors of cognitive decline after cardiac operation. Ann. Thorac. Surg., 1995, 59 : 1326-1330.
66. OKUIZUMI K., ONODERA O., NAMBA Y., IKEDA K., YAMAMOTO T. et al. Genetic association of the very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer's disease. Nat. Genet., 1995, 11 : 207-209.
67. OTT A., BRETELER M. M., VAN HARSKAMP F., CLAUS J. J., VAN DER CAMMEN T. J. et al. Prevalence of Alzheimer's disease and vascular dementia : association with education. The Rotterdam study. Br. Med. J., 1995, 310 : 970-973.
68. PEREZ-TUR J., FROELICH S., PRIHAR G., CROOK R., BAKER M. et al. A mutation in Alzheimer's disease destroying a splice acceptor site in the presenilin-1 gene. Neuroreport., 1995, 7 : 297-301.
69. PERICAK-VANCE M. A., BASS M. P., YAMAOKA L. H., GASKELL P. C., SCOTT W. K. et al. Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12. JAMA, 1997, 278 : 1237-1241.
70. PERICAK-VANCE M. A., BEBOUT J. L., GASKELL-PC J., YAMAOKA L. H., HUNG W. Y. et al. Linkage studies in familial Alzheimer disease : evidence for chromosome 19 linkage. Am. J. Hum. Genet., 1991, 48 : 1034-1050.
71. RATOVITSKI T., SLUNT H. H., THINAKARAN G., PRICE D. L., SISODIA S. S. et al. Endoproteolytic processing and stabilization of wild-type and mutant presenilin. J. Biol. Chem., 1997, 272 : 24536-24541.
72. ROCCA W. A., AMADUCCI L. A., SCHOENBERG B. S. Epidemiology of clinically diagnosed Alzheimer's disease. Ann. Neurol, 1986, 19 : 415-424.
73. ROGAEV E. I., SHERRINGTON R., ROGAEVA E. A., LEVESQUE G., IKEDA M. et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature, 1995, 376 : 775-778.
74. ROGAEVA E., PREMKUMAR S., SONG Y., SORBI S., BRINDLE N. et al. Evidence for an Alzheimer disease susceptibility locus on chromosome 12 and for further locus heterogeneity. JAMA, 1998, 280 : 614-618.
75. ROSES A. D. Genetic testing for Alzheimer disease. Practical and ethical issues. Arch. Neurol., 1997, 54 : 1226-1229.
76. ROSES A. D., SAUNDERS A. Head injury, amyloid beta and Alzheimer's disease. Nat. Med., 1995, 1 : 603-604.
77. SALBAUM J. M., WEIDEMANN A., LEMAIRE H. G., MASTERS C. L., BEYREUTHER K. The promoter of Alzheimer's disease amyloid A4 precursor gene. EMBO J., 1988, 7 : 2807-2813.
78. SCHELLENBERG G. D., BIRD T. D., WIJSMAN E. M., ORR H. T., ANDERSON L. et al. Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science, 1992, 258 : 668-671.
79. SCHENK D., BARBOUR R., DUNN W., GORDON G., GRAJEDA H. et al. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature, 1999, 400 : 173-177.
80. SCHMECHEL D. E., SAUNDERS A. M., STRITTMATTER W. J., CRAIN B. J., HULETTE C. M. et al. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc. Natl Acad. Sci. U.S.A., 1993, 90 : 9649-9653.
81. SELKOE D. J. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature, 1999, 399 : A23-A31.
82. SHERRINGTON R., ROGAEV E. I., LIANG Y., ROGAEVA E. A., LEVESQUE G. et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature, 1995, 375 : 754-760.
83. SINHA S., ANDERSON J. P., BARBOUR R., BASI G. S., CACCAVELLO R. et al. Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature, 1999, 402 : 537-540.
84. SLOOTER A. J., BRETELER M. B., OTT A., VAN BROECKHOVEN C., VAN DUIJN C. M. APOE genotyping in differential diagnosis of Alzheimer's disease. Lancet, 1996, 348 : 334.
85. SPIELMAN R. S., EWENS W. J. A sibship test for linkage in the presence of association : the sib transmission/disequilibrium test. Am. J. Hum. Genet., 1998, 62 : 450-458.
86. ST-GEORGE HYSLOP P., HAINES J., ROGAEV E., MORTILLA M., VAULA G. et al. Genetic evidence for a novel familial Alzheimer's disease locus on chromosome 14. Nat. Genet., 1992, 2 : 330-334.
87. ST-GEORGE-HYSLOP P. H. Molecular genetics of Alzheimer's disease. Biol. Psychiatry, 2000, 47 : 183-199.
88. ST. GEORGE-HYSLOP P., TANZI R. E., POLINSKY R. J., HAINES J. L., NEE L. et al. The genetic defect causing familial Alzheimer's disease maps on chromosome 21. Science, 1987, 235 : 885-890.
89. STRITTMATTER W. J., SAUNDERS A. M., SCHMECHEL D., PERICAK-VANCE M., ENGHILD J. et al. Apolipoprotein E : high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A., 1993, 90 : 1977-1981.
90. TANG M. X., STERN Y., MARDER K., BELL K., GURLAND B. et al. The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics. JAMA, 1998, 279 : 751-755.
91. TAPIOLA T., PIRTTILA T., MIKKONEN M., MEHTA P. D., ALAFUZOFF I. et al. Three-year follow-up of cerebrospinal fluid tau, beta-amyloid 42 and 40 concentrations in Alzheimer's disease. Neurosci. Lett., 2000, 280 : 119-122.
92. THEUNS J., CRUTS M., DEL-FAVERO J., GOOSSENS D., DAUWERSE H. et al. Determination of the genomic organization of human presenilin 1 by fiber-FISH analysis and restriction mapping of cloned DNA. Mamm. Genome, 1999, 10 : 410-414.
93. THINAKARAN G., BORCHELT D. R., LEE M. K., SLUNT H. H., SPITZER L. et al. Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron, 1996, 17 : 181-190.
94. VAN BROECKHOVEN C., BACKHOVENS H., CRUTS M., DE W. G., BRUYLAND M. et al. Mapping of a gene predisposing to early-onset Alzheimer's disease to chromosome 14q24. 3. Nat. Genet., 1992, 2 : 335-339.
95. VAN BROECKHOVEN C., HAAN J., BAKKER E., HARDY J. A., VAN HUL W. et al. Amyloid beta protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch). Science, 1990, 248 : 1120-1122.
96. VAN DUIJN C. M., CLAYTON D., CHANDRA V., FRATIGLIONI L., GRAVES A. B. et al. Familial aggregation of Alzheimer's disease and related disorders : a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int. J. Epidemiol., 1991, 20 Suppl 2 : S13-S20.
97. VAN DUIJN C., DE K. P., WEHNERT A., DE V. J., BRONZOVA J. B. et al. The apolipoprotein E epsilon 2 allele is associated with an increased risk of early-onset Alzheimer's disease and a reduced survival. Ann. Neurol., 1995, 37 : 605-610.
98. VAN GASSEN G., DE JONGHE C., PYPE S., VAN CRIEKINGE W., JULLIAMS A. et al. Alzheimer's disease associated presenilin 1 interacts with HC5 and ZETA, subunits of the catalytic 20S proteasome. Neurobiol. Dis., 1999, 6 : 376-391.
99. VASSAR R., BENNETT B. D., BABU-KHAN S., KAHN S., MENDIAZ E. A. et al. beta-Secretase Cleavage of Alzheimer's Amyloid Precursor Protein by the Transmembrane Aspartic Protease BACE. Science, 1999, 286 : 735-741.
100. WEISGRABER K. H., MAHLEY R. W. Human apolipoprotein E : the Alzheimer's disease connection. FASEB J., 1996, 10 : 1485-1494.
101. WISNIEWSKI H. M., BANCHER C., BARCIKOWSKA M., WEN G. Y., CURRIE J. Spectrum of morphological appearance of amyloid deposits in Alzheimer's disease. Acta Neuropathol. (Berl. ), 1989, 78 : 337-347.
102. WISNIEWSKI K. E., DALTON A. J., MCLACHLAN C., WEN G. Y., WISNIEWSKI H. M. Alzheimer's disease in Down's syndrome : clinicopathologic studies. Neurology, 1985, 35 : 957-961.
103. WRAGG M., HUTTON M., TALBOT C. Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease. Alzheimer's Disease Collaborative Group. Lancet, 1996, 347 : 509-512.
104. YAN R., BIENKOWSKI M. J., SHUCK M. E., MIAO H., TORY M. C. et al. Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature, 1999, 402 : 533-537.
105. YOSHIKAI S., SASAKI H., DOH-URA K., FURUYA H., SAKAKI Y. Genomic organization of the human-amyloid beta-protein precursor gene. Gene, 1991, 102 : 291-292.